We use essential cookies (authentication, your saved goals/stack) by default. With your permission we'll also enable privacy-respecting analytics (Vercel Web Analytics, anonymous load-time metrics) and error-replay diagnostics (Sentry — DOM snapshots only when an error fires) so we can fix bugs faster. Learn more about cookies
Topical cosmetic peptide — not a dietary supplement
SNAP-8 is a topical cosmetic ingredient, not a supplement you take internally and not a drug. It is sold legally in skincare products to affect the appearance of skin (such as wrinkles). The evidence below comes mostly from small, often industry-funded studies of topical application, so treat the effect sizes cautiously. This page is for transparency and education, not a recommendation.
What the evidence says
Most SNAP-8 studies are mechanism or observational rather than RCTs that measure a clinical effect — keep findings provisional.
Most evidence is from mixed-quality randomised trials published 2010–2022.
Based on 5 studies · 1 RCT
Confidence
LowBy outcome
The current evidence for SNAP-8 is insufficient to assign an evidence score, based on 5 indexed studies. A topical 'anti-wrinkle' cosmetic peptide (acetyl octapeptide-3), an elongated relative of argireline that is marketed to relax expression lines by mimicking a SNARE-complex fragment. Honest appraisal: independent human evidence for SNAP-8 specifically is minimal; most support is manufacturer data and extrapolation from argireline. A topical cosmetic ingredient, not a supplement or drug. Representative study: PMID 23417317.
The commonly studied dose of SNAP-8 is Topical cosmetic only — applied as formulated in a serum/cream (commonly ~3–10% of the supplier's peptide solution). Not ingested; not a supplement.. Individual needs vary — start at the lower end of the range and adjust based on how you respond.
Afamelanotide
Mostly mechanism / observationalA synthetic α-melanocyte-stimulating-hormone (α-MSH) analogue and melanocortin-1-receptor (MC1R) agonist that drives eumelanin production. IMPORTANT: distinguish two very different things. (1) The PRESCRIPTION DRUG afamelanotide (Scenesse) is a 16 mg subcutaneous implant placed by a clinician, FDA-approved (2019) and EMA-approved (2014) to prevent phototoxicity in adults with erythropoietic protoporphyria (EPP) — backed by genuine Phase 3 RCTs. (2) Grey-market 'melanotan I' injected for cosmetic tanning is the SAME molecule sold unregulated, of unknown purity/dose, and is unsafe — associated with mole/nevus changes and is not a supplement. This entry covers the drug honestly; it is not a recommendation to self-inject.
Last reviewed June 2026 · evidence from 5 studies · how we score
This information is for educational purposes only. It is not a substitute for professional medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any supplement or medication.
SNAP-8 (acetyl octapeptide-3 / acetyl glutamyl heptapeptide-1)
A topical 'anti-wrinkle' cosmetic peptide (acetyl octapeptide-3), an elongated relative of argireline that is marketed to relax expression lines by mimicking a SNARE-complex fragment. Honest appraisal: independent human evidence for SNAP-8 specifically is minimal; most support is manufacturer data and extrapolation from argireline. A topical cosmetic ingredient, not a supplement or drug.
Independent human evidence for SNAP-8 specifically is minimal — most support is manufacturer data, formulation papers, and extrapolation from the better-studied argireline; poor skin permeability limits real-world wrinkle effects, so the evidence is weak and indirect.
SNAP-8 (acetyl octapeptide-3) is a topical cosmetic peptide patterned on the N-terminal end of SNAP-25, a protein in the SNARE complex that mediates neurotransmitter (acetylcholine) release at the neuromuscular junction.
It is an elongated analog of argireline (acetyl hexapeptide-3/-8) and is marketed on the same premise: that by competing with SNAP-25 in SNARE assembly it modestly reduces the muscle contractions that cause expression wrinkles — a topical, far weaker, needle-free analogy to botulinum toxin.
The honest evidence picture is that rigorous, independent human efficacy data for SNAP-8 specifically are sparse; the better-controlled cosmetic-peptide trial evidence is for argireline, and much SNAP-8 support comes from manufacturer studies, formulation papers, and reviews.
A central limitation for all such peptides is skin permeability — these are relatively large, hydrophilic molecules that penetrate the stratum corneum poorly, so real-world effect sizes on wrinkles are small and depend heavily on formulation and delivery.
SNAP-8 is regulated as a cosmetic ingredient sold for appearance, not a dietary supplement or a drug; it is applied topically and is generally well tolerated. The score reflects small, mostly indirect/topical evidence.
SNAP-8 mimics the N-terminus of SNAP-25 and is proposed to compete in SNARE-complex assembly, modestly reducing acetylcholine release and muscle contraction in expression lines.
By dampening micro-contractions in superficial facial muscles it is marketed to soften dynamic wrinkles — a far weaker, topical analogy to neuromodulator injections.
How SNAP-8 works — from molecular targets to health outcomes. Click an edge to see supporting research.This visualization is in beta — pathways are being refined and expanded.
Tap node to isolate • Pinch to zoom • Tap edge for research
Topical cosmetic only — applied as formulated in a serum/cream (commonly ~3–10% of the supplier's peptide solution). Not ingested; not a supplement.
Can be taken without food
| Form | Type |
|---|---|
| 🧴Topical leave-on serum / cream (acetyl octapeptide-3) | Recommended |
Formulated at a few percent of the supplier's peptide solution; effect depends heavily on the finished formulation and delivery.
Minimum: 4 weeks
Optimal: 8 weeks
Cycling: Not required
Note: Applied topically once or twice daily as part of a leave-on serum or cream; not ingested.
Dose-response data unavailable. The current published research for SNAP-8 does not provide sufficient dose-specific outcome data to generate reliable dose-response curves.
Refer to the Dosage & Timing section above for recommended dose ranges based on available evidence.
Marketed to modestly reduce the appearance of dynamic wrinkles with regular topical use; real effect sizes are small.
Poor stratum-corneum permeability of large hydrophilic peptides limits how much active reaches its target.
Little rigorous third-party human data for SNAP-8 specifically; most support is manufacturer/extrapolated.
Patch-test first; topical peptides are generally well tolerated but irritation is possible.
Likely low risk topically given minimal absorption, but specific data are lacking — discuss with a clinician.
Manage expectations — topical effect is far smaller than neuromodulator injections.
Tip: Topical peptides are generally well tolerated; patch-test if sensitive.
Timing is flexible for SNAP-8 — consistent daily use matters more than the time of day. Topical skincare ingredient applied to the skin; not ingested or scheduled.
SNAP-8 is generally safe at recommended doses, with a few precautions worth noting. The most commonly reported side effects are local irritation. Use caution if any of these apply to you: Known hypersensitivity to the peptide or formulation.
Melanotan-1
Mostly mechanism / observationalA grey-market injectable α-MSH analog sold for tanning ('the Barbie drug'). Chemically it is the SAME peptide as the approved drug afamelanotide (Scenesse). Honest appraisal: as an unregulated tanning injectable it has no efficacy/safety validation; its evidence base belongs to the regulated form for a rare blood disorder. Research-use-only.